Assessment and communication by the food and Drug Administration (FDA) of hepatosplenic T-cell lymphoma (HSTCL) risk in children and young adults with Inflammatory Bowel Disease (IBD) treated with tumor Necrosis Factor (TNF) antagonists and thiopurines: P-157.


    loading  Checking for direct PDF access through Ovid

Abstract

Abstract unavailable for this article.


    loading  Loading Related Articles